Viewing Study NCT00232258


Ignite Creation Date: 2025-12-25 @ 12:16 AM
Ignite Modification Date: 2026-01-02 @ 8:09 AM
Study NCT ID: NCT00232258
Status: COMPLETED
Last Update Posted: 2008-12-10
First Post: 2005-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ulcerative Colitis View
None Inflammatory Bowel Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NK1 Antagonist View
None Inflammatory Bowel Disease View
None Mesalamine View